Patient Guide: A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 141 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05508789
Status: 🟢 Enrolling Now
Condition: Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Tauopathies, Neurodegenerative Diseases, Neurocognitive Disorders, Mental Disorders
Phase: PHASE3

Find a Study Location Near You

This study is available at 141 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • ABB,
  • Banfield,
  • Buenos Aires,
  • • And 138 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily